CD8A and lymphopenia: Interestingly, clinical studies have reported a decrease in CD4+ and CD8+ T lymphocyte counts in COVID-19 patients [63, 64], and, therefore, the effects of R848 could be recapitulating the lymphopenia observed in this disease.